NCT00402116 2020-08-06Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) PatientsEli Lilly and CompanyPhase 1/2 Completed72 enrolled 19 charts
NCT00960492 2014-09-22Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With GlioblastomaExelixisPhase 1 Completed26 enrolled